Patents
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
01/1999
01/05/1999US5856481 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
01/05/1999US5856330 Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
12/1998
12/30/1998WO1998058905A1 Novel amidrazone derivatives having antifungal activity
12/30/1998CN1041418C Xanthine derivatives as adenosine A1 receptor antagonists
12/29/1998CA2045478C Xanthine compounds
12/23/1998WO1998057645A1 Hepatic edema remedy
12/23/1998WO1998057644A1 Preventive and remedy for drug-induced nephropathy
12/23/1998EP0885224A1 Process for preparing ganciclovir derivatives
12/23/1998EP0885223A1 Famciclovir monohydrate
12/23/1998CN1202896A Purine derivatives and processes for their preparation
12/22/1998CA1340283C Substituted sulfonyldiamides, process for their preparation, and their use as herbicides and plant growth regulators
12/17/1998WO1998056803A1 Novel optically active nucleoside derivative, its manufacturing method and anti-hbv agent containing the derivative thereof
12/17/1998WO1998056376A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
12/17/1998WO1998042322A3 Antitussive compositions
12/17/1998CA2293400A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
12/16/1998CN1201794A Process for preparation of (1S,4R)-or(1R,4S)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol
12/15/1998US5849906 Antigenic conjugates of polycyclic aromatic hydrocarbons to nucleosides
12/15/1998US5849893 Nucleic acid-binding oligomers possessing C-branching for therapy and diagnostics
12/10/1998WO1998035967A3 Biazacyclic crf antagonists
12/09/1998EP0882727A1 Novel purine derivatives
12/09/1998EP0882058A1 Novel nucleoside derivatives and process for preparing the same
12/09/1998EP0882050A1 Process for preparing purine derivatives
12/09/1998CN1201463A Novel nucleoside derivatives and process for preparing same
12/08/1998US5846485 Electrochemiluminescent reaction utilizing amine-derived reductant
12/02/1998EP0880521A1 Synthesis of acyclic nucleosides
12/02/1998EP0880505A1 Acylated 4-amino- and 4-hydrazinopyrimidines and their use as pesticides
12/02/1998EP0719265B1 Nucleoside derivatives, methods for the manufacture thereof and specific polyclonal and monoclonal antibodies of said derivatives
12/02/1998CN1040980C Second messenger cell signaling inhibitors
12/01/1998US5843943 Compounds for inhibition of ceramide-mediated signal transduction
11/1998
11/26/1998WO1998052949A1 Carbocyclic nucleoside hemisulfate and its use in treating viral infections
11/26/1998WO1998052948A1 Compounds for inhibition of ceramide-mediated signal transduction
11/26/1998WO1998052940A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/26/1998WO1998052898A1 Pharmaceutical agents for the treatment of cerebral amyloidosis
11/26/1998WO1998052571A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89
11/26/1998WO1998052570A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89
11/26/1998CA2291115A1 Substituted pyrazoles as p38 kinase inhibitors
11/26/1998CA2290818A1 Pharmaceutical agents for the treatment of cerebral amyloidosis
11/26/1998CA2289655A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89
11/26/1998CA2289654A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89
11/26/1998CA2287484A1 Compounds for inhibition of ceramide-mediated signal transduction
11/25/1998EP0879820A1 Benzamide analogues, useful as PARP (ADP-Ribosyltransferase, ADPRT) DNA repair enzyme inhibitors
11/25/1998EP0879235A1 Purine and guanine derivatives
11/24/1998US5840990 Intermediates to carbocyclic nucleosides
11/24/1998US5840891 Viricides with improved absorption
11/24/1998US5840890 Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
11/24/1998US5840763 Treatment of a latent infection of herpes viruses
11/24/1998US5840729 Attenuating cognitive deficit
11/24/1998CA2159989C 8-substituted xanthines as selective adenosine receptor agents
11/24/1998CA2155130C Xanthine derivatives as adenosine a1 receptor antagonists
11/19/1998WO1998051697A2 Method for producing polymers having nucleo-bases as side-groups
11/19/1998DE19720216A1 New isonitrile compounds
11/18/1998EP0878548A2 Multistep process for the preparation of (1S,4R)- and/or (1R,4S)-4-(2-Amino-6-Chlor-9-H-purin-9-yl)-2-cyclopentene-1-methanol
11/18/1998EP0877746A1 Process for preparing purine derivatives
11/18/1998CN1040759C Carbo-acyclic nucleoside derivs. as antiviral and antineoplastic agents
11/17/1998US5837871 Nucleoside analogs
11/17/1998US5837703 Amino-alcohol substituted cyclic compounds
11/11/1998CN1040646C Enatiomeric hydroxylated xanthine compound
11/10/1998US5834474 Enantiomerically pure B--D--dioxolane nucleosides with selective anti-hepatitus B virus activity
11/04/1998EP0874848A1 Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells
11/04/1998EP0874847A1 Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof
11/04/1998EP0874846A1 Purine derivatives and processes for their preparation
11/04/1998EP0874631A1 Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application
11/04/1998CN1198158A Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
11/03/1998US5831092 7-benzyl, quaternization
11/03/1998US5831075 Reaction with an oxzolidine-2,5-dione
11/03/1998US5830898 Enantiomerically pure β-di-dioxolane-nucleosides with selective anti-hepatitis B virus activity
10/1998
10/29/1998WO1998047509A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
10/29/1998CA2286673A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
10/28/1998EP0873340A1 Heterocyclic substituted cyclopentane compounds
10/28/1998EP0873339A1 Purine and guanine derivatives as pnp inhibitors
10/27/1998US5827875 Inhibitors of microsomal triglyceride transfer protein and method
10/21/1998EP0739351A4 Monomeric diols and phosphate linked oligomers formed therefrom
10/21/1998CN1196728A Prolylendopeptidase inhibitors
10/20/1998US5824677 Substituted with heterocyclic ring, antiinflammatory, immunosuppressive
10/14/1998EP0869967A2 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
10/14/1998EP0869953A1 Nucleoside derivatives and process for preparing thereof
10/13/1998US5821367 Reacting a diacylguanine and an alkylating agent in the absence of an acid catalyst and a solvent
10/13/1998US5821366 1,3-disubsituted-zanthines to treat diseases associated with proteins that mediate cellular activity
10/13/1998CA1340084C Esters of 9-(2-hydroxyethoxymethyl)guanine having antiviral properties
10/13/1998CA1340083C Esters of 9-(2-hydroxyethoxymethyl)guanine having antiviral properties
10/06/1998US5817812 Antiviral nucleoside intermediates
10/06/1998US5817811 Amidation of the correspond esterified amine compound with a carboxylated nucleotide base
10/06/1998US5817672 Imidazopyridines
10/06/1998US5817661 Trans cyclopentanyl purine analogs useful as immunosuppressants
10/06/1998US5817660 Trans cyclopentanyl purine analogs useful as immunosuppressants
10/06/1998US5817639 Purine 4'-thioarabinonucleosides
10/01/1998WO1998042322A2 Antitussive compositions
09/1998
09/30/1998EP0867192A2 Combinatory compositions for the treatment of dementia containing at least a compound having acetylcholinesterase-inhibitory or muscarinic activity and a compound that enhances the endogenous extracellular adenosine levels
09/24/1998WO1998041522A1 Synthesis, anti-human immunodeficiency virus and anti-hepatitis b virus activities of 1,3-oxaselenolane nucleosides
09/23/1998EP0865439A1 Combinatorial libraries having aminodiol monomer subunits
09/23/1998EP0539421B1 Novel oxazolyl derivatives
09/23/1998CN1193623A Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
09/22/1998US5811534 Purine-based compounds for inclusion into oligonucleotides
09/22/1998US5811236 Electrochemiluminescent rhenium moieties and methods for their use
09/16/1998CN1192904A Composite preparation for treatment of dementia
09/15/1998US5808147 Oxidation hydrolysis of the corresponding sulfonated compound
09/15/1998US5808134 Cyclopropane derivatives and method of preparing the same
09/15/1998US5808027 N-2 substituted purines in oligonucleotides
09/15/1998US5807862 Therapeutic compounds containing pyrimidinyl moieties
09/15/1998US5807861 Amine substituted xanthinyl compounds
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 120